Financial Health Assessment: Stinky Stuff Ltd

1. Financial Health Score: B-

Explanation: While the company possesses a robust overall net worth and a strong asset base, it is currently exhibiting symptoms of cash flow anemia and profitability distress. The recent shift from steady equity growth to a significant retained loss, coupled with severely depleted cash reserves, suggests the business is experiencing a period of acute operational stress despite its historically strong constitution.

2. Key Vital Signs

• Net Assets (Equity): £2,702,139
  • Interpretation: The company's overall net worth remains very healthy in absolute terms. However, this is down from £2,927,054 in 2024, indicating a drop in retained earnings.
• Cash Reserves: £47,528
  • Interpretation: Dangerously low. This is a dramatic drop from £107,753 last year and a peak of £586,880 in 2020. The business is suffering from severe cash flow anemia, leaving it with very little liquidity to handle unexpected expenses or trading disruptions.
• Current Ratio (Working Capital Health): 1.58
  • Interpretation: Calculated as Current Assets (£990,333) divided by Current Liabilities (£625,913). A ratio above 1 indicates the business can cover its short-term debts, but the heavy reliance on debtors rather than cash makes this position fragile.
• Debtors (Accounts Receivable): £925,082
  • Interpretation: An arterial blockage. A massive 93% of the company's current assets are tied up in unpaid invoices rather than cash. This explains the cash drought.
• Profitability: Estimated £225k Loss
  • Interpretation: Retained earnings dropped from £2,926,934 to £2,702,019. Because the profit and loss account is not filed, we can diagnose a roughly £225k loss for the year—a significant hemorrhage compared to previous years of steady growth.

3. Diagnosis

Condition: Acute Cash Flow Anemia with Profitability Distress

The financial data reveals a business that has historically enjoyed a strong constitution, growing its net assets from £23k in 2016 to over £3.2M by 2022. However, the last three years show the patient is unwell.

The primary symptom is cash flow anemia. The company's cash reserves have drained by over 90% since 2020 (from £586k down to £47k). This is directly caused by a severe arterial blockage in debtors. Nearly a million pounds is owed to the business by its customers. If these debts are aging or uncollectable, the business's apparent liquidity is a mirage.

Furthermore, the patient is hemorrhaging profitability. The drop in the P&L reserve indicates a loss of approximately £225,000 in the latest financial year, eroding the equity base.

A secondary, structural concern is the phantom mass of intangible assets. The balance sheet carries £2,081,630 in goodwill, which has zero amortisation. Goodwill represents the premium paid for an acquisition in the past. Because it is not being written down, it inflates the net assets by over £2M. If this acquisition is the one currently underperforming and causing the losses, this asset may be significantly impaired, meaning the true tangible net worth of the business is closer to £620,000.

4. Recommendations

To restore the business to full health, the following interventions are prescribed:

1. Clear the Arterial Blockage (Debt Collection): Immediate and aggressive credit control is required. The £925k in debtors must be converted to cash. Implement stricter payment terms, offer early payment discounts, and escalate overdue accounts to collections. This is the fastest way to cure the cash anemia.
2. Stop the Profitability Hemorrhage: Conduct an urgent operational review to identify the root cause of the £225k loss. Trim non-essential expenditures and review margins on product lines to ensure the business isn't selling at a loss.
3. Assess the Phantom Mass (Goodwill Impairment Review): The directors must review the £2.08M goodwill asset for impairment. If the acquired business is underperforming (as the recent loss suggests), this asset should be written down to reflect reality. While this reduces net assets on paper, it provides a more honest diagnosis of the company's tangible health.
4. Stabilize the Pulse (Cash Flow Management): With only £47k in the bank, the company is one unexpected bill away from a cardiac arrest. Negotiate longer payment terms with suppliers (creditors) to keep cash in the business longer, and consider whether the increasing long-term liabilities (£467k, up from £321k) can be restructured to ease short-term pressure.